Stocks and securities in focus
| Security | Change (%) | 1w ▲ | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc. | -6.360% | - | - | - | - | - | - |
| Affimed N.V. | 0.090% | - | - | - | - | - | - |
| Lipocine Inc. | - | - | - | - | - | - | - |
| Viking Therapeutics Inc | 2.380% | -15.822% | -4.348% | 228.668% | 179.325% | 774.329% | 656.857% |
| Immunic Inc. | -0.250% | -12.181% | -1.554% | -16.620% | -15.804% | -85.145% | -90.205% |
| Bavarian Nordic A/S | -1.680% | -11.793% | 25.060% | 69.620% | 30.285% | -33.326% | 36.973% |
| WAVE Life Sciences Ltd | -2.130% | -10.769% | -15.636% | 14.286% | 1.310% | -6.995% | - |
| Caredx Inc | 1.510% | -10.213% | -2.357% | 171.556% | 110.690% | -59.603% | - |
| Syros Pharmaceuticals Inc. | 2.190% | -9.272% | -70.851% | -62.050% | -79.242% | -96.914% | - |
| Cardiff Oncology Inc. | 3.220% | -8.489% | -2.454% | 13.033% | 44.985% | -69.472% | 11.072% |
| SELLAS Life Sciences Group Inc | -6.160% | -8.076% | -3.080% | -27.995% | 9.744% | -86.481% | -82.948% |
| AC Immune Ltd | 2.040% | -8.007% | -14.422% | -11.620% | -38.356% | -55.335% | -43.703% |
| Personalis Inc | -0.700% | -7.660% | 53.169% | 243.568% | 132.404% | -74.205% | - |
| Halozyme Therapeutics Inc. | 0.410% | -7.618% | 6.998% | 48.263% | 57.637% | 49.930% | 269.427% |
| United Therapeutics | 1.670% | -5.228% | 2.870% | 48.264% | 57.276% | 77.159% | 328.062% |
| Carbylan Therapeutics Inc | -2.650% | -5.172% | -1.786% | 8.911% | 0.917% | -34.911% | -19.118% |
| Regenxbio Inc | 1.980% | -4.630% | -6.364% | -36.420% | -38.323% | -63.423% | -65.390% |
| Exact Sciences | 2.030% | -4.550% | 1.524% | -27.213% | -22.253% | -39.150% | -51.396% |
| Intuitive Surgical Inc | 0.980% | -4.446% | 0.141% | 52.691% | 39.160% | 39.403% | 178.562% |
| Teva Pharmaceutical Industries Ltd ADR | -0.920% | -4.386% | 3.810% | 81.667% | 75.429% | 105.919% | 157.075% |
| Corvus Pharmaceuticals Inc | -2.080% | -4.206% | 19.661% | 143.448% | 132.237% | 54.825% | 6.937% |
| Cellectar BioSciences Inc. | -1.550% | -3.535% | 9.770% | -10.748% | -16.228% | -77.262% | - |
| MannKind Corp. | 2.770% | -2.756% | 15.874% | 37.394% | 63.323% | 40.911% | 395.410% |
| Ultragenyx Pharmaceutical Inc. | -1.780% | -2.745% | 11.211% | 29.167% | 14.286% | -41.988% | 20.097% |
| Immutep LTD ADR | -2.560% | -2.521% | 33.333% | 29.609% | 6.422% | -34.463% | 73.601% |
| UCB S.A. | 0.780% | -2.495% | 2.168% | 94.242% | 103.518% | 69.649% | 134.971% |
| Gritstone Oncology Inc | 3.040% | -2.122% | -10.540% | -72.899% | -77.158% | -95.588% | - |
| Kala Pharmaceuticals Inc. | -0.870% | -1.914% | -4.026% | -52.013% | -21.396% | -96.225% | - |
| Catalyst Pharmaceutical Partners Inc | 0.250% | -1.829% | 7.279% | 51.092% | 15.701% | 319.505% | 199.667% |
| Exelixis Inc. | 2.200% | -0.775% | -7.393% | 11.514% | 5.347% | 36.917% | 31.925% |